[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vaccinations in December", "description": "Light at the end of the tunnel. Cavalry coming over the hill. End of the beginning and the beginning of the end. In other words, things are looking better for next year.", "link": "https://www.youtube.com/watch?v=T5QkrSfI0lI", "date_published": "2020-11-21 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Weekend Update", "description": "US excess deaths\n\nCurrently above average in 50 States\n\nhttps://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm#dashboard\n\nMarch 15 to November 7\n\nDeaths nationwide, 18 % percent higher than normal\n\nDeaths above normal, 326,000\n\nCovid deaths, 251,715\n\nUS trends\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nDonald Trump, Jr., (42) tested positive on Friday, has entered quarantine\n\nCanadian\n\nToronto prepares 28 day lockdown Monday\n\nA normal Christmas is quite frankly right out of the question\n\nMexico\n\nOver 1 million confirmed cases\n\nTest confirmed deaths, 100,000\n\nUK\n\nhttps://coronavirus.data.gov.uk/details/cases\n\nhttps://covid.joinzoe.com/data#interactive-map\n\nONS\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/20november2020\n\n8 November to 14 November 2020\n\nEngland\n\nPrevalence, 664,700 infections\n\nOne in 80 people\n\n38,900 new cases per day\n\nRates increasing\n\nLondon, East of England South East\n\nRates decreasing \n\nNorth West, East Midlands\n\nHighest positivity rates\n\nSecondary school-aged, older teenagers, young adults\n\nWales\n\nPositivity rates peaked end of October\n\nOne in 165\n\nNorthern Ireland\n\nRates decreasing over past four weeks\n\nOne in 135 \n\nScotland\n\nRates levelled of\n\nOne in 155\n\nWHO and remdesivir (20th November)\n\nhttps://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients\n\nhttps://www.dw.com/en/coronavirus-who-advises-against-remdesivir-for-hospitalized-covid-19-patients/a-55671134?maca=en-NL-Corona-Compact\n\nhttps://bnf.nice.org.uk/drug/remdesivir.html\n\nConditional recommendation against the use of remdesivir in hospitalized patients\n\nRegardless of disease severity\n\nCurrently no evidence that remdesivir improves survival and other outcomes\n\nGuideline, developed by international guideline development group\n\n28 clinical care experts, 4 patient-partners, one ethicist\n\nMatch scientific standards with the speed required to respond to an ongoing pandemic\n\nWHO Solidarity Trial, 3 other randomized controlled trials\n\nN = 7000\n\nInsufficient evidence of an important effect on: \n\nMortality\n\nNeed for mechanical ventilation\n\nTime to clinical improvement\n\nOther patient-important outcomes\n\nSupported continued enrollment in trials evaluating remdesivir.\n\nA conditional recommendation\n\nWhen the evidence around the benefits and risks of an intervention are less certain\n\nIn this case, there is a conditional recommendation against the use of remdesivir\n\nThis means that there isn\u2019t enough evidence to support its use.\n\nUS pharmaceutical company Gilead\n\nDisputes the findings\n\nWHO's findings were yet to be subjected to peer review\n\nRemdesivir is currently approved for use as a COVID-19 in over 50 countries\n\nCost\n\nhttps://www.bmj.com/content/371/bmj.m4457\n\nA treatment cycle may take 5-10 days\n\nA five day course of treatment for one patient costs around $2340 (\u00a31773; \u20ac1976) for government programmes\n\n$3120 for private insurers\n\nGilead has reached agreements to make cheaper generic versions available in low and middle income countries\n\n(Tamiflu costs less than $75 per course of treatment to shorten symptom duration for patients with influenza)", "link": "https://www.youtube.com/watch?v=SWFFREep6tQ", "date_published": "2020-11-21 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "US trends, ventilation and low cost vaccine", "description": "United States\n\nPopulation, 328 million\n\nCases, + 161,398 + 164,495 = 11,465,722\n\nDeaths, 249,670 (0.076%)\n\nMississippi\n\nhttps://rt.live\n\nRt = 0.9\n\nCases, + 1,395 = 138,791\n\nUP 53% in past 14 days\n\nDeaths, + 18 = 3,691\n\nUp 11% in past 14 days\n\nHospitalizations on 19 November = 926\n\nUp 24% in past 14 days\n\nhttps://www.nytimes.com/interactive/2020/us/mississippi-coronavirus-cases.html\n\nStates\n\nhttps://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days\n\nTrends\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nOfficial US hospitalizations\n\nhttps://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html\n\nThursday, 26 November 2020\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/holidays/thanksgiving.html\n\nMultisystem Inflammatory Syndrome in Children (MIS-C)\n\nhttps://www.cdc.gov/mis-c/cases/index.html\n\nCases, 1,163\n\n98% tested positive\n\n2% has had reported contacts\n\nMost cases develop with a 2 to 4 week delay\n\nMale 56%\n\n0ne to 14 years, average 8 years\n\nCases in Hispanics or Latinos, 412\n\nCases in Black, Non-Hispanic, 396\n\nDeaths, 20\n\nHands Face Space and Ventilate\n\nhttps://edition.cnn.com/2020/11/19/us/gym-ventilation-covid-trnd/index.html\n\nBlacksburg, Virginia\n\nCivil and environmental engineer\n\nTen feet pace (6 recommended) \n\nVentilation\n\nMore air flow than recommended by American Society of Heating, Refrigerating and Air-Conditioning Engineers\n\nWe don't see outbreaks above a certain threshold\n\nAnd the gym with the open doors was way above that\n\nCarbon dioxide monitor to track indoor levels\n\nTape on the floor to mark areas\n\nNo wandering around the gym\n\nNo partner workouts\n\nVentilation redesign\n\nA gym trainer exposed 50 \n\nNo one else got sick\n\nSome decided to get tested, all tested negative\n\nFollowed up for 2 weeks\n\nOxford vaccine phase 2 publications\n\nEasy to store\n\n\u00a33 per dose\n\nUK way out, 100 million doses\n\nhttps://covid19vaccinetrial.co.uk/phase-ii-trial-publication\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32466-1/fulltext\n\nLate-stage clinical trials, UK, US, Brazil, South Africa, Japan, Russia\n\n50,000 participants globally\n\nWhen????\n\nhttps://www.bbc.co.uk/news/health-54993652\n\nProf Andrew Pollard, (Study lead from Oxford)\n\nabsolutely delighted with the results\n\nwe're seeing the immune responses look exactly the same, even in those who are over 70 years of age\n\nLevels of efficacy\n\nNeutralising antibodies\n\nT cells\n\nnot there yet\n\nData release probably, before Christmas\n\nNo competition with other vaccines\n\nMultiple vaccines needed, We will need all of them to protect people around the globe\n\nRussia\n\nhttps://www.dw.com/en/coronavirus-digest-russia-africa-surpass-2-million-cases/a-55658580\n\nCases, + 23,610 \n\nUnited States, India, Brazil, France, Russia\n\nDeaths, + 463 = 34,850\n\nMoscow is the worst hit area\n\nWHO\n\nEurope, one death every 17 seconds (WHO)\n\nSurge in cases, Europe and the Americas\n\nCountries, case finding, care and isolation, cluster investigations, adequate testing with rapid results, contact tracing and supported quarantine, are facing much less disruption.\n\nThose countries that are letting the virus run unchecked are playing with fire\n\nFurther needless deaths and suffering\n\nA significant number of people experiencing long-term effects of the virus\n\nMental health pressures\n\nAct fast, act now, act decisively\n\nHealth being seen as an investment rather than a cost \n\nA new collective way forward is needed", "link": "https://www.youtube.com/watch?v=aYbO7c0Kgyw", "date_published": "2020-11-20 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]